000 01482 a2200421 4500
005 20250516202242.0
264 0 _c20150224
008 201502s 0 0 eng d
022 _a1543-8392
024 7 _a10.1021/mp4006968
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNaguib, Youssef Wahib
245 0 0 _aSolid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation.
_h[electronic resource]
260 _bMolecular pharmaceutics
_cApr 2014
300 _a1239-49 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aCell Line, Tumor
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aDocetaxel
650 0 4 _aDoublecortin Protein
650 0 4 _aFemale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aTaxoids
_xchemistry
650 0 4 _aTissue Distribution
650 0 4 _aTransition Temperature
650 0 4 _aTriglycerides
_xchemistry
700 1 _aRodriguez, B Leticia
700 1 _aLi, Xinran
700 1 _aHursting, Stephen D
700 1 _aWilliams, Robert O
700 1 _aCui, Zhengrong
773 0 _tMolecular pharmaceutics
_gvol. 11
_gno. 4
_gp. 1239-49
856 4 0 _uhttps://doi.org/10.1021/mp4006968
_zAvailable from publisher's website
999 _c23632863
_d23632863